1. Hamano, F., Kuribayashi, H., Iwagawa, T., Tsuhako, A., Nagata, K., Sagara, H., Shimizu, T., Shindou, H., and Watanabe, S. Mapping membrane lipids in the developing and adult mouse retina under physiological and pathological conditions using mass spectrometry. J. Biol. Chem. 2021 16;296:100303. doi:10.1016/j.jbc.2021.100303.
2. Kawai, H., Osawa, Y., Matsuda, M., Tsunoda, T., Yanagida, K., Hishikawa, D., Okawara, M., Sakamoto, Y., Shimagaki, T., Tsutsui, Y., Yoshida, Y., Yoshikawa, S., Hashi, K., Doi, H., Mori, T., Yamazoe, T., Yoshio, S., Sugiyama, M., Okuzaki, D., Komatsu, H., Inui, A., Tamura-Nakano, M., Oyama, C., Shindou, H., Kusano, H., Kage, M., Ikegami, T., Yanaga, K., Kanto, T. Sphingosine-1-phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathy. Hepatology 2021 in press
3. Valentine, WJ., Mostafa, SA., Tokuoka, SM., Hamano, F., Inagaki, NF., Nordin, JZ., Motohashi, N., Kita, Y.,Aoki1, Y., Shimizu, T., Shindou, H. (corresponding author). Lipidomic analyses reveal specific alterations of phosphatidylcholine in dystrophic mdx muscle. Frontiers in Physiology 2022 Jan 12;12:698166. doi:10.3389/fphys.2021.698166.
4. Senoo, N., Akahori, T., Ichida, H., Miyoshi, N., Morita, A., Shimizu, T., Shindou, H., Miura, S. Fasting increases 18:2-containing phosphatidylcholines to complement the decrease in 22:6-containing phosphatidylcholines in mouse skeletal muscle. PLoS One. 2021 Jul 26;16(7):e0255178. doi:10.1371/journal.pone.0255178.
5. Kobayashi, A., Ito, A., Shirakawa, I., Tamura, A., Tomono, S., Shindou, H., Hedde, PN., Tanaka, M., Tsuboi,N., Ishimoto, T., Akashi-Takamura, S., Maruyama, S., Suganami, T. Dietary supplementation with eicosapentaenoic acid inhibits plasma cell differentiation and attenuates lupus autoimmunity. Frontiers in Immunology 2021 Jun 15;12:650856. doi: 10.3389/fimmu.2021.650856.
6. Valentine, WJ, Yanagida, K., Kawana, H., Kono, N., Noda-N, N., Aoki, J., Shindou, H. (corresponding author). Update and nomenclature proposal for mammalian lysophospholipid acyltransferases which create membrane phospholipid diversity. J. Biol. Chem. 2022 Jan;298(1):101470. doi: 10.1016/j.jbc.2021.101470.
7. Hoshino, Y., Okuno, T., Saigusa, D., Kano, K., Yamamoto, S., Shindou, H., Aoki, J., Uchida, K,, Takehiko Yokomizo, Nobuko Ito. Lysophosphatidic acid receptor 1/3 antagonist inhibits the activation of satellite glial cells and reduces acute nociceptive responses. FASEB J. 2022 Apr;36(4):e22236. doi:10.1096/fj.202101678R.
8. Tanosaki, T., Mikami, Y., Shindou, H*. (*corresponding author), Suzuki, T., Hashidate-Yoshida, T., Hosoki,K., Kagawa, S., Miyata, J., Kabata, H., Masaki, K., Hamamoto, R., Kage, H., Miyashita, N., Makita, K.,Matsuzaki, H., Suzuki, Y., Mitani, A., Nagase, T., Shimizu, T., Fukunaga, K*. Lysophosphatidylcholine Acyltransferase 1 Deficiency Promotes Pulmonary Emphysema via Apoptosis of Alveolar Epithelial Cells.Inflammation. 2022 in press
9. 上園保仁、進藤英雄、宮野加奈子「血小板活性化因子(PAF)のシグナル伝達に関わる分子をターゲットとする創薬開発」中外医学社Clinical Neuroscience 2021 年39 巻9号1061-1063
10. 上園保仁、進藤英雄、宮野加奈子「血小板活性化因子(PAF)の細胞内シグナルおよびその生理作用」中外医学社Clinical Neuroscience 2021 年39 巻8 号926-928